Hyperliquid Strategies INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
Hyperliquid Strategies Inc. reported a significant net loss for Q2 2025, driven by unrealized losses on HYPE digital assets and a large write-off from the Sonnet acquisition, despite substantial capital raises.
Hyperliquid Strategies Inc. completed its business combination with Sonnet BioTherapeutics and Rorschach, raising significant capital and listing on Nasdaq, despite initial operating losses.